GlassScriptPhysician profile
Gilbert L Wergowske
NPI 1205862042
$2,539.71
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $688 · 2021: $737 · 2022: $28.03.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $538.19 | 2019-2021 | |
| Lilly USA, LLC | $374.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $267.42 | 2019-2022 | |
| Amgen INC. | $170.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $149.08 | 2019-2021 | |
| Pfizer INC. | $116.58 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $96.70 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $84.02 | 2019-2020 | |
| Celgene Corporation | $65.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $61.15 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.11 | 2019 | |
| Tesaro, INC. | $53.22 | 2019 | |
| Abbvie INC. | $49.57 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.29 | 2019 | |
| Eisai INC. | $38.12 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $34.05 | 2021 | |
| Sanofi Pasteur INC. | $33.54 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $33.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.66 | 2019 | |
| Exelixis INC. | $23.94 | 2019 | |
| Incyte Corporation | $23.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.95 | 2020 | |
| Amag Pharmaceuticals, INC. | $20.75 | 2019 | |
| Allergan, INC. | $19.49 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.54 | 2019 | |
| Hologic Sales and Service, LLC | $18.25 | 2020 | |
| Circassia INC. | $17.89 | 2019 | |
| Genzyme Corporation | $17.31 | 2019 | |
| Qiagen, LLC | $16.78 | 2020 | |
| Cranial Technologies, INC | $15.29 | 2021 | |
| Advanced Accelerator Applications | $13.33 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.06 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Wergowske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.